ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density
- PMID: 34794600
- DOI: 10.1016/j.jacr.2021.09.002
ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density
Abstract
Mammography remains the only validated screening tool for breast cancer, however, there are limitations to mammography. One of the limitations of mammography is the variable sensitivity based on breast density. Supplemental screening may be considered based on the patient's risk level and breast density. For average-risk women with nondense breasts, the sensitivity of digital breast tomosynthesis (DBT) screening is high; additional supplemental screening is not warranted in this population. For average-risk women with dense breasts, given the decreased sensitivity of mammography/DBT, this population may benefit from additional supplemental screening with contrast-enhanced mammography, screening ultrasound (US), breast MRI, or abbreviated breast MRI. In intermediate-risk women, there is emerging evidence suggesting that women in this population may benefit from breast MRI or abbreviated breast MRI. In intermediate-risk women with dense breasts, given the decreased sensitivity of mammography/DBT, this population may benefit from additional supplemental screening with contrast-enhancedmammography or screening US. There is strong evidence supporting screening high-risk women with breast MRI regardless of breast density. Contrast-enhanced mammography, whole breast screening US, or abbreviated breast MRI may be also considered. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Keywords: AU; Appropriate Use Criteria; Appropriateness Criteria; Breast MRI; Breast MRI abbreviated; Breast ultrasound; Digital breast tomosynthesis; Mammography with IV contrast.
Copyright © 2021 American College of Radiology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Rethinking the ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density.J Am Coll Radiol. 2022 May;19(5):595. doi: 10.1016/j.jacr.2021.11.011. Epub 2022 Jan 22. J Am Coll Radiol. 2022. PMID: 35077683 No abstract available.
-
Response.J Am Coll Radiol. 2022 May;19(5):596. doi: 10.1016/j.jacr.2022.01.017. Epub 2022 Mar 21. J Am Coll Radiol. 2022. PMID: 35331691 No abstract available.
Similar articles
-
ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density: 2024 Update.J Am Coll Radiol. 2025 May;22(5S):S405-S423. doi: 10.1016/j.jacr.2025.02.023. J Am Coll Radiol. 2025. PMID: 40409891
-
ACR Appropriateness Criteria® Breast Cancer Screening.J Am Coll Radiol. 2017 Nov;14(11S):S383-S390. doi: 10.1016/j.jacr.2017.08.044. J Am Coll Radiol. 2017. PMID: 29101979
-
ACR Appropriateness Criteria® Evaluation of Nipple Discharge.J Am Coll Radiol. 2017 May;14(5S):S138-S153. doi: 10.1016/j.jacr.2017.01.030. J Am Coll Radiol. 2017. PMID: 28473070 Review.
-
ACR Appropriateness Criteria® Breast Implant Evaluation.J Am Coll Radiol. 2018 May;15(5S):S13-S25. doi: 10.1016/j.jacr.2018.03.009. J Am Coll Radiol. 2018. PMID: 29724416
-
ACR Appropriateness Criteria® Palpable Breast Masses: 2022 Update.J Am Coll Radiol. 2023 May;20(5S):S146-S163. doi: 10.1016/j.jacr.2023.02.013. J Am Coll Radiol. 2023. PMID: 37236740 Review.
Cited by
-
Performance of Supplemental US Screening in Women with Dense Breasts and Varying Breast Cancer Risk: Results from the Breast Cancer Surveillance Consortium.Radiology. 2024 Aug;312(2):e232380. doi: 10.1148/radiol.232380. Radiology. 2024. PMID: 39105648 Free PMC article.
-
The road to breast cancer screening with diffusion MRI.Front Oncol. 2023 Feb 21;13:993540. doi: 10.3389/fonc.2023.993540. eCollection 2023. Front Oncol. 2023. PMID: 36895474 Free PMC article. Review.
-
Advances and Future Directions in Molecular Breast Imaging.J Nucl Med. 2022 Jan;63(1):17-21. doi: 10.2967/jnumed.121.261988. Epub 2021 Dec 9. J Nucl Med. 2022. PMID: 34887334 Free PMC article. Review.
-
Digital Breast Tomosynthesis Plus Ultrasound Versus Digital Mammography Plus Ultrasound for Screening Breast Cancer in Women With Dense Breasts.Korean J Radiol. 2023 Apr;24(4):274-283. doi: 10.3348/kjr.2022.0649. Korean J Radiol. 2023. PMID: 36996902 Free PMC article.
-
Breast density analysis of digital breast tomosynthesis.Sci Rep. 2023 Oct 31;13(1):18760. doi: 10.1038/s41598-023-45402-x. Sci Rep. 2023. PMID: 37907569 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical